ArticleInvestigative ophthalmology & visual science2024
A New Retest-Stable Tortuosity Metric for Retinal Vessel Analyses.
Article in Investigative ophthalmology & visual science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- VascX Models: Deep Ensembles for Retinal Vascular Analysis From Color Fundus Images.Translational vision science & technology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Purpose: Existing retinal vessel tortuosity metrics lack standardization and retest reliability, hindering their clinical utility. Our study addresses this gap by introducing a novel metric, coined as the "vascular curvature index" (VCI), to enhance accuracy and consistency in biomarkers associated with medical conditions. We assess VCI's performance in terms of retest reliability in healthy subjects to transform early detection and monitoring approaches for various diseases. Methods: We recruited 44 patients for a single-session study, capturing fundus images before and after a five-minute break. Using AutoMorph, we generated vessel segmentation maps and evaluated retest reliability using multiple tortuosity metrics. The VCI was introduced and statistically compared to existing metrics. We performed a paired one-sided t-test to test for significantly improved retest reliability of our newly proposed metric. We analyzed distribution histograms, Fisher-Pearson coefficient of skewness, and correlation matrices for further insights. Results: VCI is the most retest-reliable metric, statistically surpassing other curvature metrics, except inverse spherical radius tortuosity. With a somewhat negatively distributed pattern (coefficient of skewness of -0.52), VCI exhibits the strongest correlation with the second most retest-reliable metric; inverse-radius-tortuosity (Pearson and Spearman correlation of 0.7 and 0.72, respectively). Its correlation with angle-tortuosity is lower (Pearson and Spearman correlation of 0.05 and 0.07, respectively). Conclusions: The VCI emerges as a highly retest-reliable metric with a relatively normal distribution in healthy patients. Further investigation is warranted to evaluate its clinical performance in real-world applications, potentially influencing proactive healthcare interventions and personalized treatment decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.